Citi raised the firm’s price target on Procter & Gamble to $190 from $177 and keeps a Buy rating on the shares as part of a Q2 earnings preview for the beverage and personal care space. The firm expects another quarter with contribution from hyperinflationary pricing in emerging margins offset by currency headwinds, moderating pricing in domestic markets, with only modest improvements in volumes. Citi continues to favor names that can sustain above-peers growth, aided by emerging market exposure and lower private label penetration.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble Unveils Stock Market Investment Strategies
- Savvy Shopping Habits Impact Staples Companies’ Profits
- Playtex maker ticks lower after UC Berkeley study on tampon toxins
- Arsenic and lead found in study measuring toxic metals in tampons
- PG, ATO: 2 “Strong Buy” Dividend Aristocrat Stocks, According to Top Analysts